University of California San Francisco
Give to UCSFAn extended course of Paxlovid appears to help some patients with long COVID, according to a study by UCSF researchers that suggests this treatment option holds promise for some of those struggling with lasting symptoms.
UCSF scientists developed a way to deliver radiation just to cancerous cells, rather than attacking both cancerous and healthy tissue. The therapy combines a drug to mark the cancer cells for destruction and a radioactive antibody to kill them.
A new technology uses engineered T cells that act as immune “referees” to soothe overreacting immune responses. They also can mop up inflammatory molecules without lowering the entire body’s immune shields.
Nearly 50 UCSF researchers have been named to Clarivate’s list of most influential scientists for 2024.
UCSF researchers develop customizable SNIPR sensors that activate engineered cells only near tumors, promising precise cancer therapies with minimal side effects.
A decade-long effort has resulted in a new, rapid genomic test to diagnose rare infectious diseases in the brain and lungs.
In June, UCSF treated its first patient with E-SYNC, its first homegrown CAR-T therapy, one of the first to show promise in treating certain types of brain cancers. This story builds on previous coverage to provide an overview of CAR-T therapy, accessibility and future horizons of applications in cancer and other illnesses like HIV.
A study shows how the keto diet affects the microbiome in ways that may reduce autoimmune responses in the gut.
Oral health has long been siloed from the rest of a person's health. But increasingly, researchers and clinicians, including those at UCSF, are finding ties between a person's oral health and their overall health.
Several cases of the bird flu in humans have been reported in California's Central Valley in 2024. This Q&A explores how the virus spreads, how to prevent infection and whether this is something to be we need to actively protect against.
A new study on doxy-PEP sheds light on whether people who are regular users become resistance to this treatment, which often serves as a “morning after” pill to prevent sexually transmitted diseases.
UCSF officially broke ground on the Barbara and Gerson Bakar Research and Academic Building on Sept. 28, which will house state-of-the-art research facilities, and will also serve as the new home for the UCSF School of Nursing.
Breast cancer is the second leading cause of cancer deaths in the U.S. and worldwide, pointing to the continuing need to improve treatment strategies and therapies that better patient survival and
An extra-long summer surge driven by new variants has prompted the early release of updated COVID-19 vaccines. A UCSF expert tells us what new vaccines could mean for the summer surge, who should get vaccinated, and when/where to get your vaccines.
Seth Blumberg, MD, PhD, explains the viral disease mpox, and what the recent emergency declaration from the World Health Organization means for us.
A study determines that a life-saving, inexpensive antibiotic, azithromycin, must be given to all children up to 5 years old in Sub-Sharan Africa to realize its full potential.
Face masks remain crucial in preventing the spread of COVID-19, even with vaccine availability. The decision to wear masks depends on vaccination status, risk factors, and local hospitalizations. Medical N95, KN95, or KF94 masks offer the best protection.
Scientists at UCSF discovered how kids were developing multisystem inflammatory syndrome in children (MIS-C), a mysterious, life-threatening condition following a COVID infection.
Researchers Micheal Peluso and Valerie Flaherman answer questions about what we know about one of COVID’s most enduring mysteries, including how to potentially reduce your risk and who is most likely to develop long COVID.